Journal Home
Search for

Articles in Press

Return to articles in press list

Identifying an accurate pre-screening tool in geriatric oncology

Eliane KellenaCorresponding Author Informationemail address, Paul Bulensb, Laura Deckxc, Harry Schoutend, Marjan Van Dijke, Ilse Verdonckb, Frank Buntinxac

Accepted 10 December 2009. published online 08 January 2010.
Corrected Proof

Abstract 

The use of comprehensive geriatric assessment (CGA) in cancer patients older than 70 is recommended. Three pre-screening instruments have been proposed: the abbreviated comprehensive geriatric assessment (aCGA), the Vulnerable Elders Survey (VES-13), and the Groningen frailty index (GFI). The objective of the study was to identify the most efficient pre-screening tool that accurately determines individuals who may benefit from the entire CGA. A total of 113 elderly cancer patients were assessed by means of the aCGA, VES-13, GFI and the full CGA. The sensitivity, specificity of the three instruments was calculated, using the results from the entire CGA as the gold standard for the GFI and the VES-13. The aCGA was assessed whether each sub-component reliably predicts impairment on each sub-component of the full CGA.

The majority of the participants were defined as being at risk of vulnerability: 68.14% had two or more impairments of the CGA or were cognitively impaired. The physical and disability questions are useful, but all other screening instruments miss too many cases.

a Leuven Centre of Cancer Prevention, University Hospitals - Leuven, Belgium

b Limburg Oncology Centre – Hasselt, Belgium

c Department of General Practice and Research Institute Caphri, Maastricht University, The Netherlands

d Department of Internal Medicine, Section Hematology/Oncology, Academic Hospital Maastricht, The Netherlands

e Department of Internal Medicine, Section Oncology, Academic Hospital Maastricht, The Netherlands

Corresponding Author InformationCorresponding author at: Leuven Centre of Cancer Prevention, University Hospitals - Leuven, Belgium. Tel.: +32 016 33 74 93; fax: +32 016 33 74 80.

PII: S1040-8428(09)00247-9

doi:10.1016/j.critrevonc.2009.12.002